Clinical challenges in accurate assessment of severe aortic stenosis with a special focus on low-gradient aortic stenosis and normal ejection fraction

Cardiology in Review

Volumn 19, Issue 5, 2011, Pages 239-245

  Barboza, Joaquim ^a   Krishnan, Naveen ^a   Ananthasubramaniam, Karthikeyan ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

aortic stenosis; cardiac catheterization; echocardiography; low flow low gradient aortic stenosis; preserved ejection fraction

Indexed keywords

AGED; AORTA STENOSIS; CASE REPORT; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HUMAN; QUANTITATIVE DIAGNOSIS; REVIEW; TREATMENT INDICATION;

AGED; AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; STROKE VOLUME;

EID: 80051756845     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3182213f23     Document Type: Review

References (55)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630-634. (Pubitemid 27116107)
2. Pohle K, Otte M, Maffert R, et al. Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography. Mayo Clin Proc. 2004;79:1242-1246. (Pubitemid 39299066)
3. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844-853. (Pubitemid 24242754)
4. Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-2665. (Pubitemid 34596044)
5. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205-2209. (Pubitemid 33043301)
6. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-1356.
7. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231. (Pubitemid 44268973)
8. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885-892. (Pubitemid 32202459)
9. Kolh P, Kerzmann A, Honore C, et al. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg. 2007;31:600-606. (Pubitemid 46400496)
10. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611-617. (Pubitemid 30659472)
11. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268. (Pubitemid 46276943)
12. Hachicha Z, Dumesnil JG, Bogaty P, et al. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856-2864. (Pubitemid 46869673)
13. Clavel MA, Fuchs C, Burwash IG, et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation. 2008;118:S234-S242.
14. Pai RG, Varadarajan P, Razzouk A. Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Ann Thorac Surg. 2008;86:1781-1789.
15. Minners J, Allgeier M, Gohlke-Baerwolf C, et al. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J. 2008;29:1043-1048. (Pubitemid 351844672)
16. Barasch E, Fan D, Chukwu EO, et al. Severe isolated aortic stenosis with normal left ventricular systolic function and low transvalvular gradients: pathophysiologic and prognostic insights. J Heart Valve Dis. 2008;17:81-88.
17. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009;54:1003-1011.
18. Pibarot P, Dumesnil JG. Low-flow, low-gradient, normal ejection fraction aortic stenosis. Curr Cardiol Rep. 2010;12:108-115.
19. Jander N, Minners J, Holme I, et al. Outcome of patients with low gradient "severe" aortic stenosis and preserved ejection fraction. Circulation. 2011;123:887-895.
20. Weidemann F, Herrmann S, Stork S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120:577-584.
21. Page A, Dumesnil JG, Clavel MA, et al. Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol. 2010;55:1867-1874.
22. Carabello BA. Clinical practice. Aortic stenosis. N Engl J Med. 2002;346:677-682.
23. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46:291-298. (Pubitemid 40966858)
24. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003;348:1756-1763. (Pubitemid 36514706)
25. Aurigemma GP, Silver KH, Priest MA, et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195-202.
26. Takeda S, Rimington H, Smeeton N, et al. Long axis excursion in aortic stenosis. Heart. 2001;86:52-56. (Pubitemid 32977781)
27. Khaw AV, von Bardeleben RS, Strasser C, et al. Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosis. Int J Cardiol. 2009;136:64-71.
28. Shahgaldi K, Manouras A, Brodin LA, et al. Direct measurement of left ventricular outflow tract area using three-dimensional echocardiography in biplane mode improves accuracy of stroke volume assessment. Echocardiography. 2010;27:1078-1085.
29. Shiran A, Adawi S, Ganaeem M, et al. Accuracy and reproducibility of left ventricular outflow tract diameter measurement using transthoracic when compared with transesophageal echocardiography in systole and diastole. Eur J Echocardiogr. 2009;10:319-324.
30. Lembcke A, Kivelitz DE, Borges AC, et al. Quantification of aortic valve stenosis: head-to-head comparison of 64-slice spiral computed tomography with transesophageal and transthoracic echocardiography and cardiac catheterization. Invest Radiol. 2009;44:7-14.
31. Malyar NM, Schlosser T, Barkhausen J, et al. Assessment of aortic valve area in aortic stenosis using cardiac magnetic resonance tomography: comparison with echocardiography. Cardiology. 2008;109:126-134.
32. Pibarot P, Dumesnil JG. Assessment of aortic valve stenosis severity when the gradient does not fit with the valve area. Heart. 2010;96:1431-1433.
33. Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15:865-870. (Pubitemid 24223943)
34. Razzolini R, Gerosa G, Leoni L, et al. Transaortic gradient is pressuredependent in a pulsatile model of the circulation. J Heart Valve Dis. 1999;8:279-283. (Pubitemid 29274330)
35. Kadem L, Dumesnil JG, Rieu R, et al. Impact of systemic hypertension on the assessment of aortic stenosis. Heart. 2005;91:354-361. (Pubitemid 40299219)
36. Mascherbauer J, Fuchs C, Stoiber M, et al. Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro. Eur Heart J. 2008;29:2049-2057.
37. Little SH, Chan KL, Burwash IG. Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosis. Heart. 2007;93:848-855. (Pubitemid 46998988)
38. Kadem L, Pibarot P, Dumesnil JG, et al. Independent contribution of left ventricular ejection time to the mean gradient in aortic stenosis. J Heart Valve Dis. 2002;11:615-623.
39. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl E):57-64.
40. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001;86:381-386. (Pubitemid 32889370)
41. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005;26:1309-1313. (Pubitemid 41435462)
42. Lancellotti P, Moonen M, Magne J, et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol. 2010;105:383-388.
43. Feuchtner GM, Muller S, Grander W, et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. J Heart Valve Dis. 2006;15:494-498. (Pubitemid 44122677)
44. Niederberger J, Schima H, Maurer G, et al. Importance of pressure recovery for the assessment of aortic stenosis by Doppler ultrasound. Role of aortic size, aortic valve area, and direction of the stenotic jet in vitro. Circulation. 1996;94:1934-1940. (Pubitemid 26349308)
45. Garcia D, Dumesnil JG, Durand LG, et al. Discrepancies between catheter and Doppler estimates of valve effective orifice area can be predicted from the pressure recovery phenomenon: practical implications with regard to quantification of aortic stenosis severity. J Am Coll Cardiol. 2003;41:435-442. (Pubitemid 36164499)
46. Baumgartner H, Stefenelli T, Niederberger J, et al. " Overestimation" of catheter gradients by Doppler ultrasound in patients with aortic stenosis: a predictable manifestation of pressure recovery. J Am Coll Cardiol. 1999;33:1655-1661.
47. Garcia D, Pibarot P, Dumesnil JG, et al. Assessment of aortic valve stenosis severity: a new index based on the energy loss concept. Circulation. 2000;101:765-771. (Pubitemid 30100083)
48. Kume T, Okura H, Kawamoto T, et al. Clinical implication of energy loss coefficient in patients with severe aortic stenosis diagnosed by Doppler echocardiography. Circ J. 2008;72:1265-1269.
49. Marechaux S, Carpentier E, Six-Carpentier M, et al. Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Arch Cardiovasc Dis. 2010;103:227-235.
50. Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol. 2006;47:2229-2236. (Pubitemid 43795081)
51. Cramariuc D, Cioffi G, Rieck AE, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. JACC Cardiovasc Imaging. 2009;2:390-399.
52. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22:1-23.
53. Baumgartner H, Otto CM. Aortic stenosis severity: do we need a new concept? J Am Coll Cardiol. 2009;54:1012-1013.
54. Lancellotti P, Lebois F, Simon M, et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation. 2005;112:I377-I382. (Pubitemid 41266702)
55. Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation. 2004;110:356-362. (Pubitemid 38955506)